The Centers for Disease Control and Prevention opioid guidelines: potential for unintended consequences and will they be abused?

被引:12
|
作者
Pergolizzi, J. V., Jr. [1 ]
Raffa, R. B. [3 ,4 ]
LeQuang, J. A. [2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] NEMA Res Inc, Naples, FL USA
[3] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
[4] Temple Univ, Dept Pharmaceut Sci, Sch Pharm, Philadelphia, PA 19122 USA
关键词
guidelines; opioid; pain;
D O I
10.1111/jcpt.12444
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
What is known and objectiveThe Centers for Disease Control and Prevention (CDC) have published guidelines for opioid prescribing, with the goal of helping guide clinicians to make safe prescribing choices. In the form of 12 statements, the CDC offers guidance that at times is not supported by the evidence or introduces new concepts (such as a requirement that opioids improve function). Our objective was to examine the new guidelines in terms of how well they could strike the balance between keeping opioids accessible to those who need them while appropriately restricting their use. What is new and conclusionThe CDC guidelines offer some reasonable and laudable guidance, but they also make some recommendations which are not supported by current scientific evidence. We also noted that the urgent need for greater education among opioid prescribers was not addressed in the new guidelines.
引用
收藏
页码:592 / 593
页数:2
相关论文
共 50 条